[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2633 followers Created: 2025-07-14 13:02:23 UTC $NBIX Neurocrine Biosciences reveals 1-year data demonstrating sustained effectiveness of CRENESSITY® (crinecerfont) in adult patients at ENDO 2025. More Info: $XBI $IBB $XPH $PPH  XXX engagements  **Related Topics** [$pph](/topic/$pph) [$xph](/topic/$xph) [$ibb](/topic/$ibb) [$xbi](/topic/$xbi) [more info](/topic/more-info) [$nbix](/topic/$nbix) [neurocrine biosciences inc](/topic/neurocrine-biosciences-inc) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/OzmosiHealth/status/1944744285708206082)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ozmosi @OzmosiHealth on x 2633 followers
Created: 2025-07-14 13:02:23 UTC
$NBIX Neurocrine Biosciences reveals 1-year data demonstrating sustained effectiveness of CRENESSITY® (crinecerfont) in adult patients at ENDO 2025.
More Info: $XBI $IBB $XPH $PPH
XXX engagements
Related Topics $pph $xph $ibb $xbi more info $nbix neurocrine biosciences inc stocks healthcare
/post/tweet::1944744285708206082